The size of the Pharmaceutical Filtration Market in Europe was worth USD 4.62 billion in 2020. It is further estimated to be growing at a CAGR of 8.7% and worth USD 7.01 billion by 2025.
The market is expected to expand at a fast rate during the forecast period. Filtration is a process that helps separate suspended particles from a medium by passing them through a membrane. It is a physical separation technique used in various industries. A multi-layer lattice is generally used and used for various processes like air and water filtration.
Factors such as technological advancements, the presence of many prominent players, and the rise in the manufacture of generic drugs and biopharmaceutical products are augmenting the pharmaceutical filtration market in Europe. Increasing demand for therapeutic biopharmaceuticals such as antibodies, hormones, and vaccines is a major factor that drives the growth of the pharmaceutical filtration market during the forecast period. However, large capital requirements and strict validation and rules are expected to hamper the market's growth.
This research report on the European Pharmaceutical Filtration Market has been segmented and sub-segmented into the following categories:
By Product:
By Technique:
By Application:
By Country:
Some of the Key Participants leading the Europe Pharmaceutical Filtration Market Profiled in the Report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Membrane filters
5.1.2.1 MCE Membrane Filters
5.1.2.2 Coated Cellulose Acetate Membrane Filters
5.1.2.3 PTFE Membrane Filters
5.1.2.4 Nylon Membrane Filters
5.1.2.5 PVDF Membrane Filters
5.1.2.6 Other Membrane Filters
5.1.3 Prefilters and depth media filters
5.1.3.1 Glass fibre filters
5.1.3.2 PTFE fibre filters
5.1.4 Single use systems
5.1.5 Cartridge and capsule filters
5.1.6 Filter holders
5.1.7 Filtration accessories
5.1.8 Other products
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By product
5.1.11 Market Share Analysis, By Product
5.2 Technique
5.2.1 Introduction
5.2.2 Microfiltration
5.2.3 Ultrafiltration
5.2.4 Nano filtration
5.2.5 Other techniques
5.2.6 Y-o-Y Growth Analysis, By Technique
5.2.7 Market Attractiveness Analysis, By Technique
5.2.8 Market Share Analysis, By Technique
5.3 Application
5.3.1 Introduction
5.3.2 Final product processing
5.3.2.1 API filtration
5.3.2.2 Sterile filtration
5.3.2.3 Protein purification
5.3.2.4 Vaccine and antibody processing
5.3.2.5 Formulation and Filling Solution Filtration
5.3.2.6 Viral Clearance
5.3.3 Raw material filtration
5.3.3.1 Media and buffer filtration
5.3.3.2 Prefiltration
5.3.3.3 Bioburden testing
5.3.4 Cell seperation
5.3.5 Water purification
5.3.6 Air purification
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 Scale of operation
5.4.1 Introduction
5.4.2 Manufacturing scale
5.4.3 Pilot scale
5.4.4 R&D scale
5.4.5 Y-o-Y Growth Analysis, By Scale of Operation
5.4.6 Market Attractiveness Analysis, By Scale of Operation
5.4.7 Market Share Analysis, By Scale of Operation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.3.5 By Scale of operation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.4.5 By Scale of operation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.1.5.5 By Scale of operation
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Pall Corporation
8.4 3M Company
8.5 Parker Hannifin Corporation
8.6 Sartorius Stedim Biotech S.A.
8.7 Eaton Corporation PLC
8.8 Amazon Filters Ltd.
8.9 Meissner Filtration Products, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports